Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income 
Trump DOJ Challenges Colorado’s Large-Capacity Magazine Ban in Second Amendment Lawsuit 
DOJ Ends Probe Into Fed Chair Jerome Powell, Boosting Kevin Warsh Confirmation Prospects 
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO 
Kuaishou Stock Jumps on Kling AI IPO Plans and $20 Billion Valuation 
Judge Orders Release of Family After Longest ICE Detention Under Trump Administration 
US Auto Industry Urges Trump to Block Chinese EV Market Access 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Ibiden Stock Surges as AI Chip Demand Boosts Profit Outlook 
The Missouri Supreme Court rejected Johnson & Johnson's appeal of a ruling by the Missouri Court of Appeals awarding $2.12 billion damages to women who blamed the company's asbestos-tainted products for their ovarian cancer.
The New Brunswick, New Jersey-based firm called the verdict a product of fundamentally flawed trial, grounded in a faulty presentation of the facts and vowed to elevate the case to the US Supreme Court.
Johnson & Johnson insists that there were decades of independent scientific evaluations that found their product safe, asbestos-free, and not cancer-causing.
In July 2018, a jury ruled that Johnson & Johnson was liable $4.69 billion to the complainants.
The Missouri Court of Appeals upheld the jury verdict on June 23 but reduced the payout to $2.12 billion after dismissing claims by 22 plaintiffs.
It said that it may be inferred from evidence that the company disregarded consumer safety for profit.
Kevin Parker, a lawyer for the plaintiffs, said that Johnson & Johnson should accept the verdict of the jury and the appellate court and compensate the victims.
Johnson & Johnson said it would set aside a $2.1 billion reserve for the verdict.
The company, which said that it would stop selling its Baby Powder talc in the US and Canada, revealed that it faces over 21,800 lawsuits claiming that its talc products contain asbestos, a known carcinogen.
Johnson & Johnson's baby powder was intensely scrutinized for safety after a 2018 Reuters investigative report said that it knew for decades that about the asbestos contamination of its talc.
Evidence showed that from at least 1971 to the early 2000s,
Johnson & Johnson's raw talc and finished powders have tested positive for small amounts of asbestos.
